What Are Semaglutides? Breaking Down the Buzzword
Wondering what semaglutides are? Get a simple breakdown of the medications, how they work, and how Eden connects you to licensed providers for evaluation.
New to semaglutide? Learn what first-time patients should know and how to connect with a licensed healthcare provider through Eden.
This content is for informational purposes only and does not constitute medical advice. Medications like semaglutide are only prescribed when medically appropriate and are dispensed through state-licensed pharmacies. Eden is not a pharmacy or healthcare provider. Eden connects individuals with independent, licensed healthcare professionals for evaluation and care coordination.
If you’re exploring treatment options to support your metabolic health, you’ve likely come across the term semaglutide. It’s been featured in headlines, patient forums, and even TV ads. But for first-time patients, the flood of information can feel overwhelming.
This article will help you understand what semaglutide is, how it works, and what to expect when talking to a licensed healthcare provider. Whether you’re curious about injections, tablets, or simply want to understand the basics, here’s what first-time patients need to know.
Semaglutide is a prescription medication that belongs to a class of drugs known as GLP-1 receptor agonists. These medications are designed to mimic the effects of a hormone in your body called GLP-1 (glucagon-like peptide-1), which plays a role in regulating blood sugar, insulin response, and appetite.
Semaglutide was originally approved in 2017 under the brand name Ozempic® for adults with type 2 diabetes. Since then, additional formulations have been approved:
Each of these medications uses semaglutide as the active ingredient, but is prescribed for different clinical reasons. A licensed healthcare provider can determine which, if any, is appropriate based on your personal health profile.
{{primary-cta}}
Rather than replacing your body’s natural hormones, semaglutide is designed to activate GLP-1 receptors, which can help regulate digestion, blood sugar levels, and how full you feel after eating.
When prescribed appropriately and paired with nutrition and lifestyle modifications, semaglutide may support improved metabolic outcomes. In a 2021 study published in The New England Journal of Medicine, participants who received semaglutide along with lifestyle intervention experienced changes in appetite and reductions in body weight.
These results were achieved under medical supervision in a controlled clinical setting. A licensed provider can help determine if similar treatment strategies might be appropriate based on your health status and goals.
If you're thinking about starting semaglutide, here are a few things to be aware of:
Eden connects you with providers who specialize in metabolic health and understand how to tailor care for new patients just beginning their treatment journey.
{{primary-cta}}
First-time patients often ask whether semaglutide is only available as a shot. While injectable formulations like Ozempic® and Wegovy® are more widely prescribed, Rybelsus® is a tablet version of semaglutide taken once daily.
The decision between an injection and a tablet depends on:
Tablets must be taken on an empty stomach under specific timing guidelines, while injections are typically administered once per week. A licensed provider will explain the pros and cons of each option during your consultation.
Starting a new treatment can feel overwhelming, especially if you're unsure where to begin. Eden is a digital health platform built to simplify that process.
Whether you’re nervous about injections or just need help getting started, Eden makes the first step easy.
{{primary-cta}}
Here are some helpful questions first-time patients can ask during their consultation:
Licensed providers on the Eden platform can walk you through all of this in a supportive and judgment-free environment.
Semaglutide is one of the most widely discussed GLP-1 medications today, and for first-time patients, understanding the basics is key. Whether you're exploring tablets or injections, this treatment may play a role in supporting your metabolic health goals when used under professional supervision.
The best way to get started is to talk to a provider who understands your unique needs. Eden helps make that connection simple, secure, and convenient.
New to Semaglutide? Connect with a licensed provider to see if this treatment may be right for you.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider or a pharmacy. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by independent, state-licensed pharmacies. Eden does not manufacture, own, or dispense any medications. Please consult a licensed healthcare provider before making any medical decisions.
Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/nejmoa2032183